Onego Bio is a startup based in the United States, most recent round Series A, 4 tracked investors.
Based in the United States, Onego Bio is a startup founded in 2020. Its most recent tracked round is Series A. Brouky records 4 investors associated with the company.
Onego Bio is a biotech company using cellular agriculture to produce animal-free egg protein. Their first product, Bioalbumen, aims to replace chicken egg white in the food industry with a sustainable alternative.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.